Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04660045
Title Early Intervention With Acalabrutinib in Patients With High Risk CLL
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Weill Medical College of Cornell University
Indications

CLL/SLL

chronic lymphocytic leukemia

Therapies

Acalabrutinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST